Developing effective cardiovascular therapies requires robust, translational preclinical data that can reliably predict ...

DYNAMIKA™ delivers SOC 2 Type II–certified, AI‑driven imaging workflows, giving pharma and biotech secure, compliant ...

Valencia, Spain and New York, January 28, 2025 – Quibim, a healthtech company focused on the use of imaging biomarkers for precision medicine, announced today the close of its $50 million Series A ...

This article explores how multiomics integration, imaging, and bioinformatics are advancing biomarker discovery, revealing ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Matthew Brier, MD, ...

Collaborative research is underway to translate scientific discovery into actionable evidence ...

—Using multimodal imaging, this 10-year prospective cohort study identified markers that could help stratify patients at high risk of progressing to advanced AMD, which may help inform clinical ...

CHICAGO, Nov. 25, 2025 /PRNewswire/ -- Using a deep learning AI model, researchers identified the first-of-its-kind biomarker of chronic stress detectable through routine imaging, according to ...

The NASH Biomarkers Market sees major opportunities in non-invasive diagnostics combining serum markers, imaging, and AI for metabolic disease management. Key growth drivers include the demand for ...

Opportunities in the Middle East imaging biomarkers market include the expansion of advanced imaging infrastructure and increased adoption of biomarker-driven clinical pathways. Driven by rising ...